For those aiming to surpass market returns, the art of stock picking is crucial. Making wise choices in stocks can greatly enhance your overall wealth.
After finishing at $27.7 in the prior trading day, Option Care Health Inc (NASDAQ: OPCH) closed at $27.5, down -0.72%. In other words, the price has decreased by -$0.72 from its previous closing price. On the day, 1.78 million shares were traded. OPCH stock price reached its highest trading level at $28.05 during the session, while it also had its lowest trading level at $27.41.
Ratios:
Our goal is to gain a better understanding of OPCH by taking a closer look at its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 22.45 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 18.51. For the most recent quarter (mrq), Quick Ratio is recorded 1.00 and its Current Ratio is at 1.52. In the meantime, Its Debt-to-Equity ratio is 0.90 whereas as Long-Term Debt/Eq ratio is at 0.88.
On January 23, 2025, Jefferies Upgraded its rating to Buy which previously was Hold and also upped its target price recommendation from $26 to $35.
BofA Securities Upgraded its Neutral to Buy on January 13, 2025, whereas the target price for the stock was revised from $26 to $33.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Sep 09 ’25 when Wright Norman L. bought 3,411 shares for $29.31 per share. The transaction valued at 99,976 led to the insider holds 15,501 shares of the business.
Pate R Carter bought 750 shares of OPCH for $20,391 on Aug 20 ’25. The Director now owns 41,910 shares after completing the transaction at $27.19 per share. On Aug 20 ’25, another insider, KRAEMER HARRY M JANSEN JR, who serves as the Director of the company, bought 36,000 shares for $27.15 each. As a result, the insider paid 977,278 and bolstered with 375,390 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, OPCH now has a Market Capitalization of 4463114240 and an Enterprise Value of 5485925376. As of this moment, Option’s Price-to-Earnings (P/E) ratio for their current fiscal year is 21.91, and their Forward P/E ratio for the next fiscal year is 14.17. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 2.06. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.83 while its Price-to-Book (P/B) ratio in mrq is 3.28. Its current Enterprise Value per Revenue stands at 1.021 whereas that against EBITDA is 13.713.
Stock Price History:
The Beta on a monthly basis for OPCH is 0.89, which has changed by -0.117741406 over the last 52 weeks, in comparison to a change of 0.15535986 over the same period for the S&P500. Over the past 52 weeks, OPCH has reached a high of $35.53, while it has fallen to a 52-week low of $21.39. The 50-Day Moving Average of the stock is -4.21%, while the 200-Day Moving Average is calculated to be -9.04%.
Shares Statistics:
The stock has traded on average 1.73M shares per day over the past 3-months and 2122550 shares per day over the last 10 days, according to various share statistics. A total of 162.29M shares are outstanding, with a floating share count of 160.39M. Insiders hold about 1.17% of the company’s shares, while institutions hold 101.12% stake in the company. Shares short for OPCH as of 1756425600 were 4653043 with a Short Ratio of 2.69, compared to 1753920000 on 4945499. Therefore, it implies a Short% of Shares Outstanding of 4653043 and a Short% of Float of 4.5.
Earnings Estimates
Its stock is currently analyzed by 6.0 different market analysts. The consensus estimate for the next quarter is $0.46, with high estimates of $0.47 and low estimates of $0.46.
Analysts are recommending an EPS of between $1.72 and $1.68 for the fiscal current year, implying an average EPS of $1.71. EPS for the following year is $1.94, with 7.0 analysts recommending between $2.04 and $1.87.
Revenue Estimates
9 analysts predict $1.41B in revenue for. The current quarter. It ranges from a high estimate of $1.44B to a low estimate of $1.37B. As of. The current estimate, Option Care Health Inc’s year-ago sales were $1.28BFor the next quarter, 9 analysts are estimating revenue of $1.46B. There is a high estimate of $1.49B for the next quarter, whereas the lowest estimate is $1.45B.
A total of 10 analysts have provided revenue estimates for OPCH’s current fiscal year. The highest revenue estimate was $5.65B, while the lowest revenue estimate was $5.57B, resulting in an average revenue estimate of $5.63B. In the same quarter a year ago, actual revenue was $5BBased on 10 analysts’ estimates, the company’s revenue will be $6.1B in the next fiscal year. The high estimate is $6.19B and the low estimate is $5.98B.
